Welcome to our dedicated page for abrdn World Healthcare SEC filings (Ticker: THW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
tekla life sciences investors is a closed-ended equity mutual fund launched and managed by tekla capital management llc. the fund invests in public equity markets across the globe. it seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. the fund primarily invests in growth stocks of small cap companies. it employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. the fund benchmarks the performance of its portfolio against the nasdaq biotech index and the s&p 500 index. it was formabrdn World Healthcare Fund reported a new insider with no share ownership. A Form 3 filing shows an individual serving as a Vice President of the fund and therefore an officer of the issuer. The filing states that no securities of abrdn World Healthcare Fund are beneficially owned by this reporting person, and both the non-derivative and derivative ownership tables are blank. The document also includes a power of attorney authorizing the signatory, dated 12/19/2025, and identifies the event date triggering the report as 12/09/2025.